<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Terbutaline</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00871</strong>&#160; (APRD00589)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00871/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00871/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00871.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00871.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00871.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00871.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00871.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00871">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Terbutalin</td><td>German</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Terbutalina</td><td>Spanish</td><td>DCIT</td></tr><tr><td>Terbutaline (sulfate de)</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>PH: Ph. Eur. 7</td></tr><tr><td>Terbutalini sulfas</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>PH: Ph. Eur. 7</td></tr><tr><td>Terbutalinsulfat</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>PH: Ph. Eur. 7</td></tr><tr><td>Terbutalinum</td><td>Latin</td><td>INN</td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Terbutaline Sulfate</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000297/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000297/thumb.png"></a></td>
        <td>
            <ul>
              <li>InChI Key: MUPQZWGSBCWCAV-UHFFFAOYNA-N</li>
              <li>Monoisotopic Mass: 323.103872721</li>
              <li>Average Mass: 323.363</li>
            </ul>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000297">DBSALT000297</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Brethaire</td><td>Novartis</td></tr><tr><td>Brethine</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Bricanyl</td><td>AstraZeneca</td></tr><tr><td>Bricardyl</td><td>Johnson</td></tr><tr><td>Bricasma</td><td>AstraZeneca</td></tr><tr><td>Bricasol</td><td>AstraZeneca</td></tr><tr><td>Dracanyl</td><td>AstraZeneca</td></tr><tr><td>Terbasmin</td><td>AstraZeneca</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>Benylin Bronchospect</td><td>Terbutaline and Guaifenesin</td></tr><tr><td>Bricanyl Expectorant</td><td>Terbutaline and Guaifenesin</td></tr><tr><td>Bricarex </td><td>Terbutaline and Guaifenesin</td></tr><tr><td>Mucosol </td><td>Terbutaline and Guaifenesin</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/sympathomimetics">Sympathomimetics</a></li>
<li><a href="/mesh/adrenergic-beta-2-receptor-agonists">Adrenergic beta-2 Receptor Agonists</a></li>
<li><a href="/mesh/bronchodilator-agents">Bronchodilator Agents</a></li>
<li><a href="/mesh/tocolytic-agents">Tocolytic Agents</a></li></ul></td></tr><tr><th>CAS number</th><td>23031-25-6</td></tr><tr><th>Weight</th><td>Average: 225.2842<br>Monoisotopic: 225.136493479</td></tr><tr><th>Chemical Formula</th><td>C<sub>12</sub>H<sub>19</sub>NO<sub>3</sub></td></tr><tr><th>InChI Key</th><td>XWTYSIMOBUGWOL-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13-16H,7H2,1-3H3</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Benzenoids</td></tr><tr><th>Class</th><td>Benzene and Substituted Derivatives</td></tr><tr><th>Subclass</th><td>Phenols and Derivatives</td></tr><tr><th>Direct parent</th><td>Resorcinols</td></tr><tr><th>Alternative parents</th><td>Secondary Alcohols; Polyols; 1,2-Aminoalcohols; Enols; Dialkylamines; Polyamines</td></tr><tr><th>Substituents</th><td>1,2-aminoalcohol; polyol; secondary alcohol; secondary aliphatic amine; polyamine; enol; secondary amine; amine; alcohol; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the resorcinols. These are compounds containing a resorcinol moiety, which is a benzene ring bearing two hydrocyl groups at positions 1 and 3.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the prevention and reversal of bronchospasm in patients 12 years of age and older with reversible, obstructive airway disease, as well as symptomatic management of reversible bronchospasm associated with bronchitis and emphysema. Also used acute IV and sub-Q therapy in selected women to inhibit uterine contractions in preterm labor (tocolysis) and prolong gestation when beneficial.</td></tr><tr><th>Pharmacodynamics</th><td>Terbutaline is a relatively selective beta2-adrenergic bronchodilator that has little or no effect on alpha-adrenergic receptors. The drug has exerts a preferential effect on beta2-adrenergic receptors but stimulates beta-adrenergic receptors less selectively than relatively selective beta2-agonists. Terbutaline appears to have a greater stimulating effect on beta-receptors of the bronchial, vascular, and uterine smooth muscles (beta2 receptors) than on the beta-receptors of the heart (beta1 receptors). This drug relaxes smooth muscle and inhibits uterine contractions, but may also cause some cardiostimulatory effects and CNS stimulation.</td></tr><tr><th>Mechanism of action</th><td>The pharmacologic effects of terbutaline are at least in part attributable to stimulation through beta-adrenergic receptors of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic- 3',5'- adenosine monophosphate (c-AMP). Increased c-AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.</td></tr><tr><th>Absorption</th><td>Approximately 30-50% if administered orally and well absorbed subcutaneously.</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td>About 90% of the drug was excreted in the urine at 96 hours after subcutaneous administration, with about 60% of this being unchanged drug. It appears that the sulfate conjugate is a major metabolite of terbutaline and urinary excretion is the primary route of elimination</td></tr><tr><th>Half life</th><td>5.5-5.9 hours</td></tr><tr><th>Clearance</th><td><ul>
	<li>311 +/- 112 mL/min</li>
</ul></td></tr><tr><th>Toxicity</th><td>Terbutaline Sulfate: Oral LD<sub>50</sub>(rat) = 8.7 g/kg; Oral LD<sub>50</sub>(mouse) = 205 mg/kg; Oral LD<sub>50</sub>(dog) = 1.5 g/kg; IP LD<sub>50</sub>(rat)= 220 mg/kg ; IP LD<sub>50</sub>(mouse) = 130 mg/kg; Oral LD<sub>50</sub>(rabbit) = &gt;8 g/kg; IV LD<sub>50</sub>(mouse) = 36 mg/kg; IV LD<sub>50</sub>(dog) = 116 mg/kg; IV LD<sub>50</sub>(rabbit) = 110 mg/kg</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.987</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.9355</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.8404</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.6335</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8954</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9672</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9067</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7678</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.7922</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.6291</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9516</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9303</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.923</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9115</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8766</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9117</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9119
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.8484
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9808
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.1080 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9548
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.9467
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Novartis pharmaceuticals corp</li>
<li>Sanofi aventis us llc</li>
<li>Aaipharma llc</li>
<li>Akorn inc</li>
<li>App pharmaceuticals llc</li>
<li>Bedford laboratories div ben venue laboratories inc</li>
<li>Hikma farmaceutica (portugal) sa</li>
<li>Teva parenteral medicines inc</li>
<li>Impax laboratories inc</li>
<li>Lannett holdings inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.akorn.com">Akorn Inc.</a></li>
<li><a href="http://www.amerisourcebergen.com">Amerisource Health Services Corp.</a></li>
<li><a href="http://www.apppharma.com">APP Pharmaceuticals</a></li>
<li><a href="http://www.astrazeneca.ca">AstraZeneca Inc.</a></li>
<li><a href="http://www.bedfordlabs.com">Bedford Labs</a></li>
<li><a href="http://www.benvenue.com">Ben Venue Laboratories Inc.</a></li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li>Dept Health Central Pharmacy</li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.gallipot.com">Gallipot</a></li>
<li><a href="http://www.globalphar.com">Global Pharmaceuticals</a></li>
<li><a href="http://www.hikma.com">Hikma Pharmaceuticals</a></li>
<li><a href="http://www.lannett.com">Lannett Co. Inc.</a></li>
<li><a href="http://www.mckesson.com">Mckesson Corp.</a></li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li><a href="http://www.novartis.com">Novartis AG</a></li>
<li><a href="http://www.nucarerx.com">Nucare Pharmaceuticals Inc.</a></li>
<li>Pharmaceutical Utilization Management Program VA Inc.</li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.rebelrx.com">Rebel Distributors Corp.</a></li>
<li>Redpharm Drug</li>
<li><a href="http://www.remedyrepack.com">Remedy Repack</a></li>
<li>Resource Optimization and Innovation LLC</li>
<li><a href="http://www.riteaid.com">Rite Aid Corp.</a></li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li>
<li>Tya Pharmaceuticals</li>
<li><a href="http://www.west-ward.com">West-Ward Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Aerosol, metered</td><td>Respiratory (inhalation)</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01193">Acebutolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00386">Alseroxylon</a></td><td>Increased arterial pressure</td></tr><tr><td><a href="/drugs/DB00321">Amitriptyline</a></td><td>The tricyclic antidepressant, amitriptyline, increases the sympathomimetic effect of terbutaline.</td></tr><tr><td><a href="/drugs/DB00543">Amoxapine</a></td><td>The tricyclic antidepressant, amoxapine, increases the sympathomimetic effect of terbutaline.</td></tr><tr><td><a href="/drugs/DB00335">Atenolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00195">Betaxolol</a></td><td>Beta-Blockers (Beta1 Selective) like betaxolol may diminish the bronchodilatory effect of Beta2-Agonists like terbutaline. Therapy should be monitored.</td></tr><tr><td><a href="/drugs/DB01295">Bevantolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00612">Bisoprolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00521">Carteolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01136">Carvedilol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01242">Clomipramine</a></td><td>The tricyclic antidepressant, clomipramine, increases the sympathomimetic effect of terbutaline.</td></tr><tr><td><a href="/drugs/DB01089">Deserpidine</a></td><td>Increased arterial pressure</td></tr><tr><td><a href="/drugs/DB01151">Desipramine</a></td><td>The tricyclic antidepressant, desipramine, increases the sympathomimetic effect of terbutaline.</td></tr><tr><td><a href="/drugs/DB01142">Doxepin</a></td><td>The tricyclic antidepressant, doxepin, increases the sympathomimetic effect of terbutaline.</td></tr><tr><td><a href="/drugs/DB00187">Esmolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00458">Imipramine</a></td><td>The tricyclic antidepressant, imipramine, increases the sympathomimetic effect of terbutaline.</td></tr><tr><td><a href="/drugs/DB01247">Isocarboxazid</a></td><td>Increased arterial pressure</td></tr><tr><td><a href="/drugs/DB00598">Labetalol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00601">Linezolid</a></td><td>Possible increase of arterial pressure</td></tr><tr><td><a href="/drugs/DB00968">Methyldopa</a></td><td>Increased arterial pressure</td></tr><tr><td><a href="/drugs/DB00264">Metoprolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00211">Midodrine</a></td><td>Increased arterial pressure</td></tr><tr><td><a href="/drugs/DB01171">Moclobemide</a></td><td>Moclobemide increases the sympathomimetic effect of terbutaline.</td></tr><tr><td><a href="/drugs/DB01203">Nadolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00540">Nortriptyline</a></td><td>The tricyclic antidepressant, nortriptyline, increases the sympathomimetic effect of terbutaline.</td></tr><tr><td><a href="/drugs/DB01580">Oxprenolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01626">Pargyline</a></td><td>Increased arterial pressure</td></tr><tr><td><a href="/drugs/DB01359">Penbutolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00780">Phenelzine</a></td><td>Increased arterial pressure</td></tr><tr><td><a href="/drugs/DB00960">Pindolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01297">Practolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00571">Propranolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00344">Protriptyline</a></td><td>The tricyclic antidepressant, protriptyline, increases the sympathomimetic effect of terbutaline.</td></tr><tr><td><a href="/drugs/DB01367">Rasagiline</a></td><td>Increased arterial pressure</td></tr><tr><td><a href="/drugs/DB00206">Reserpine</a></td><td>Increased arterial pressure</td></tr><tr><td><a href="/drugs/DB00489">Sotalol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00373">Timolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00752">Tranylcypromine</a></td><td>Increased arterial pressure</td></tr><tr><td><a href="/drugs/DB00726">Trimipramine</a></td><td>The tricyclic antidepressant, trimipramine, increases the sympathomimetic effect of terbutaline.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>